Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors Meeting Abstract
| Authors: | Prenen, H.; Kyi, C.; Van Lancker, G.; Patel, S. P.; Mittag, D.; Weaver, A.; Bol, K.; Stalbovskaya, V.; Pulini, J.; Zhou, G.; Dong, Z.; Asatiani, E.; Hodi, F. S. |
| Abstract Title: | Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors |
| Meeting Title: | ESMO Immuno-Oncology Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2021 Dec 8-11 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-12-01 |
| Start Page: | S1436 |
| Language: | English |
| ACCESSION: | WOS:000731051400139 |
| DOI: | 10.1016/j.annonc.2021.10.155 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 136P -- Source: Wos |
